| Not Yet Recruiting | Predictive Accuracy of Machine Perfusion for Kidney Transplant Outcomes in Germany NCT07348874 | University Hospital Heidelberg | — |
| Not Yet Recruiting | A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Car NCT07100925 | Ankyra Therapeutics, Inc | Phase 1 |
| Active Not Recruiting | Does Early Postoperative Fluid Management Affect Functional Delayed Graft Function After Living Donor Kidney T NCT07392996 | Ankara University | — |
| Recruiting | Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients NCT07197164 | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Phase 2 |
| Recruiting | Frailty Among Renal Transplant Recipients and Relation to Chronic Allograft Dysfunction NCT07181096 | Alexandria University | N/A |
| Recruiting | Evaluation of Thiosulfate Enhanced Organ Preservation Solution in Kidney Transplantation NCT06288152 | Alp Sener | N/A |
| Completed | Early Pharmacological and Immune Monitoring After Conversion to Belatacept in Renal Transplant Patients NCT05632523 | University Hospital, Tours | — |
| Recruiting | Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Reci NCT06025240 | Liverpool University Hospitals NHS Foundation Trust | — |
| Completed | A Study of the Correlation Between Donor UDP-Glc and Transplanted Kidney Function NCT06707272 | Qianghua Leng | — |
| Unknown | Effect of Progressive Exercise on Renal Transplant Patients NCT05876507 | Baskent University | N/A |
| Recruiting | NEgative prEssure Wound Therapy in Renal Transplant NCT07065734 | Centro Hospitalar De São João, E.P.E. | Phase 4 |
| Completed | Kidney Transplant Low-AGE Diet Study NCT05104242 | University Hospitals of Derby and Burton NHS Foundation Trust | N/A |
| Unknown | Safety and Effectiveness of COVID-19 Vaccine in Kidney Transplant Recipients NCT05156086 | Seoul National University Hospital | — |
| Active Not Recruiting | Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN NCT04572854 | Apellis Pharmaceuticals, Inc. | Phase 2 |
| Active Not Recruiting | Cognitive Outcomes in Stable Renal Transplant Patients Switched FromTacrolimus to Envarsus XR™ NCT04838288 | Vanderbilt University Medical Center | Phase 4 |
| Unknown | Influence of the Intestinal Microbiota on the Clinical Course of Renal Transplantation NCT04874896 | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | N/A |
| Unknown | Efficacy and Safety Study of Aspirin for the Prevention of Renal Artery Stenosis in Renal Transplantation Reci NCT04260828 | Henan Provincial People's Hospital | Phase 4 |
| Completed | AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNce NCT05216172 | Queen Mary University of London | Phase 2 |
| Completed | Trial to Define the Benefits and Harms of Deceased Donor Kidney Procurement Biopsies NCT03837522 | St. Louis University | N/A |
| Completed | IVIG/Rituximab vs Rituximab in Kidney Transplant With de Novo Donor-specific Antibodies NCT04033276 | Seoul National University Hospital | Phase 4 |
| Completed | The Kidney and The Brain Study - Assessment of Cognitive Impairment in Advanced CKD NCT03382444 | Natalie Garratt | — |
| Unknown | The Effect of Norepinephrine Versus Dopamine in Renal Transplant Recipients on Postoperative Graft Function NCT03107858 | Assiut University | Phase 2 / Phase 3 |
| Terminated | Characterization Of the Intestinal Microbiome Evolution After Kidney Transplant Donation or Receipt NCT03043339 | Emory University | — |
| Unknown | Effects of Nocturnal Hypertension on Sleep Quality in Renal Transplant Recipients NCT03651492 | Federico II University | — |
| Withdrawn | Efficacy of Envarsus XR and Digital Health Technology in Reducing Tacrolimus Fluctuation and Frequency of Dose NCT04711291 | Beth Israel Deaconess Medical Center | N/A |
| Completed | Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients NCT03020589 | University of North Carolina, Chapel Hill | Phase 4 |
| Completed | Assessment of Effectiveness of Belatacept Patient Alert Card in Patients Following Renal Transplantation in a NCT02581644 | Bristol-Myers Squibb | — |
| Completed | Treg Therapy in Subclinical Inflammation in Kidney Transplantation NCT02711826 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 / Phase 2 |
| Completed | Efficacy of the ALL YOU NEED is LOVE Healthcare Transition Syllabus Among Pre- and Posttransplant Adolescents NCT06836544 | Fundacion Clinica Valle del Lili | N/A |
| Unknown | Pregnancy Outcomes in Renal Transplant Recipients NCT03073434 | Unity Health Toronto | — |
| Unknown | Influence of Thymoglobuline on Phenotypic and Functional Profiles of B Lymphocytes in Renal Transplant Recipie NCT02894606 | University Hospital, Brest | — |
| Completed | Extracorporeal Shockwave Therapy in the Treatment for Erectile Dysfunction in Male Renal Transplant Recipients NCT02412345 | University of Sao Paulo | N/A |
| Completed | Belatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Stud NCT02738918 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Completed | Renal Transplant Injury and the Renin-Angiotensin System in Kids (RETASK) NCT03317925 | Wake Forest University Health Sciences | — |
| Withdrawn | A Randomized Study Assess the Safety and Efficacy of Tacrolimus vs Prograf® in Renal Transplantation Treatment NCT01244659 | EMS | Phase 3 |
| Completed | Evaluation of a Predictive Immunovirological Test Occurrence of BK Virus Nephropathy in Renal Transplant NCT02049827 | Centre Hospitalier Universitaire de Nice | N/A |
| Completed | Evaluation of Calcineurin-inhibitor Reduction With Conversion at 2 Months to Everolimus/Reduced Tacrolimus in NCT01935128 | University of Toledo Health Science Campus | Phase 4 |
| Unknown | B Cell Lymphocyte in Humoral Rejection and Alloimmunisation NCT03016455 | University Hospital, Brest | — |
| Completed | Pharmaco-economical Study in Kidney Transplantation NCT01989832 | University Hospital, Limoges | — |
| Completed | Long-term Cardiovascular Risk Following Successful Renal Transplantation NCT01728012 | Helse Stavanger HF | — |
| Withdrawn | Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcificati NCT01612299 | University of Kentucky | N/A |
| Completed | Absence of Steroid in Renal Transplantation and Digital Fibrosis Observation NCT01541176 | Nantes University Hospital | Phase 4 |
| Completed | Comparison of Medication Adherence Between Once and Twice Daily Tacrolimus in Stable Renal Transplant Recipien NCT01334333 | University of British Columbia | Phase 4 |
| Completed | Identification of Markers (Klotho-FGF23 Axis) as Determinant in the Evolution of Arterial Stiffness During the NCT02951442 | Hopital Foch | N/A |
| Unknown | Home-Care Needs in Liver or Renal Transplantation Recipients and Their Spouses NCT01380002 | National Taiwan University Hospital | — |
| Completed | Advagraf/Prograf Conversion Trial NCT01410162 | Norman Muirhead | Phase 4 |
| Completed | Pharmacokinetics of Generic to Brand Tacrolimus in Stable Renal Transplant Patients NCT01256294 | Novartis | Phase 4 |
| Unknown | Study of Cyclosporine Withdrawal Regimen in Thai Renal Transplant Recipients NCT01758107 | Chulalongkorn University | Phase 4 |
| Completed | 24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycoph NCT01169701 | Novartis Pharmaceuticals | Phase 4 |
| Unknown | Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant NCT01154387 | Tolera Therapeutics, Inc | Phase 1 / Phase 2 |
| Unknown | Renal Allograft : Evaluation of Parenchymal Fibrosis by Elastography NCT01234363 | Hospices Civils de Lyon | N/A |
| Terminated | Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney Transplant NCT01011114 | Montefiore Medical Center | N/A |
| Suspended | TIPE2 Associated With Kidney Transplant NCT01059292 | Xi'an Jiaotong University | — |
| Completed | Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Tran NCT01220050 | Mario Negri Institute for Pharmacological Research | Phase 2 |
| Completed | Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients NCT00895583 | Pfizer | Phase 4 |
| Completed | mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Trans NCT01028092 | University Hospital, Brest | Phase 3 |
| Completed | Peginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant Patien NCT00881582 | King Abdulaziz Medical City | Phase 4 |
| Completed | Telmisartan Versus Losartan in Kidney Transplantation NCT01224860 | Mario Negri Institute for Pharmacological Research | Phase 2 |
| Completed | Study of the Influence of Plasma Exchange on the Pharmacokinetics of Rituximab NCT00820469 | University Hospital, Toulouse | Phase 4 |
| Unknown | CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant Recipients NCT00737659 | Rabin Medical Center | Phase 4 |
| Completed | Latent Tuberculosis Infection in Renal Transplant Recipients NCT00682045 | Asan Medical Center | — |
| Completed | Calcineurin Inhibitor Based Immunosuppression Withdrawal NCT02117596 | Pediatric Nephrology of Alabama | N/A |
| Completed | Pediatric Kidney Transplant Study of Sirolimus, Mycophenolate Mofetil, and Corticosteroids vs Calcineurin Inhi NCT00555373 | Pediatric Nephrology of Alabama | N/A |
| Completed | Study Evaluating Rapamune® Maintenance Regimen NCT00478608 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 |
| Unknown | Ibandronate Versus Placebo in the Prevention of Bone Loss After Renal Transplantation. NCT00423384 | Smerud Medical Research International AS | Phase 2 / Phase 3 |
| Completed | A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Sta NCT00402168 | Bristol-Myers Squibb | Phase 2 |
| Completed | Measurement of Patient Reported Outcomes in Korean Renal Transplant Patients With and Without Gastrointestinal NCT00529269 | Novartis Pharmaceuticals | Phase 4 |
| Terminated | Belatacept to Prevent Organ Rejection in Kidney Transplant Patients NCT00346151 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Arterial Stiffness and Calcifications in Incident Renal Transplant Recipients NCT00547040 | Universitaire Ziekenhuizen KU Leuven | — |
| Terminated | Elastographic Imaging of Renal Transplants NCT00935727 | The University of Texas Health Science Center, Houston | Phase 1 |
| Completed | Intravenous Voriconazole in Patients With Renal Compromise NCT00332410 | University of Pittsburgh | — |
| Withdrawn | Allopurinol for Renal Transplant Associated Hypertension in Children NCT00288171 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 1 / Phase 2 |
| Completed | Enteric-Coated Mycophenolate Sodium on Quality of Life in Patients With Gastrointestinal Symptoms Related to M NCT00239005 | Novartis Pharmaceuticals | Phase 4 |
| Completed | Study of Enteric-coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Adult de Novo Renal Transplant Pa NCT00149903 | Novartis Pharmaceuticals | Phase 3 |
| Completed | The Use of ACE Inhibitors in the Early Renal Post-transplant Period NCT00270153 | Montefiore Medical Center | Phase 1 |
| Completed | Influence of Genes on Sirolimus Metabolism in Patients With Kidney Transplantation NCT00352547 | National Institutes of Health Clinical Center (CC) | — |
| Completed | Study of Tolerant Kidney Transplant Recipients NCT01338779 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Measuring Kidney Function in Kidney Transplantation NCT00212979 | Ottawa Hospital Research Institute | — |
| Completed | Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation NCT00141037 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 / Phase 2 |
| Completed | Pilot Study for HLA Identical Living Donor Renal Transplant Recipients NCT00352092 | University of Cincinnati | Phase 4 |
| Completed | "A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplant NCT00365846 | University of Wisconsin, Madison | Phase 2 |
| Completed | Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study NCT00149916 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study NCT00149864 | Novartis | Phase 3 |
| Completed | Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study NCT00149929 | Novartis | Phase 3 |